The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

    China gives unproven COVID-19 vaccines to thousands, with risks unknown

    Synopsis

    The world still lacks a proven COVID-19 vaccine, but that has not stopped Chinese officials from trying to inoculate tens of thousands, if not hundreds of thousands, of people outside the traditional testing process.

    Agencies
    The unproven vaccines could have harmful side effects. Ineffective vaccines could lead to a false sense of security and encourage behavior that could lead to even more infections.
    By Sui-Lee Wee

    First, workers at state-owned companies got dosed. Then government officials and vaccine company staff. Up next: teachers, supermarket employees and people traveling to risky areas abroad.

    The world still lacks a proven COVID-19 vaccine, but that has not stopped Chinese officials from trying to inoculate tens of thousands, if not hundreds of thousands, of people outside the traditional testing process. Three vaccine candidates are being injected into workers whom the government considers essential, along with many others, including employees of the pharmaceutical firms themselves.

    Officials are laying out plans to give shots to even more people, citing emergency use, amounting to a big wager that the vaccines will eventually prove to be safe and effective.

    China’s rush has bewildered global experts. No other country has injected people with unproven vaccines outside the usual drug trial process to such a huge scale. The vaccine candidates are in Phase 3 trials, or the late stages of testing, which are mostly being conducted outside China. The people in those trials are closely tracked and monitored. It is not clear that China is taking those steps for everyone who is getting the shots within the country.

    The unproven vaccines could have harmful side effects. Ineffective vaccines could lead to a false sense of security and encourage behavior that could lead to even more infections.

    The wide use of vaccines also raises issues of consent, especially for employees of Chinese vaccine makers and state-owned companies who might feel pressure to roll up their sleeves. The companies have asked people taking the vaccines to sign a nondisclosure agreement preventing them from talking about it to the news media.

    “My worry for the employees of the companies is it may be difficult for them to refuse,” said Dr. Kim Mulholland, a pediatrician at the Murdoch Children’s Research Institute in Melbourne, Australia, who has been involved in the oversight of many vaccine trials.

    It is not clear how many people in China have received coronavirus vaccines. Sinopharm, a Chinese state-owned company with a vaccine candidate in late-stage trials, has said hundreds of thousands of people have received its shots. Sinovac, a Beijing-based company, said more than 10,000 people in Beijing had been injected with its vaccine.
    (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Also Read

    19 Comments on this Story

    Rajagopalan Srinivasan25 days ago
    Huge advantage in being a Communist country. No questions can be asked...Thank God these unscrupulous Chinese are using their own people as guinea pigs !
    Shailesh VISPUTE25 days ago
    If they can unofficially release Virus from the "laboratory", releasing a vaccine was not a big deal...They can risk anyone lives without any burdon
    User25 days ago
    Everyone making the comments like they know everything about China, and chanting the Aatmanirbhar Bharat slogen.That's great! India will be No 1 very soon! It's in the perspective of Covid 19. India will surpass US to be the No 1 of the world! Congratulations!
    Open your eyes, check the world by your own eyes! Ask some Indians staying in China now, what kind of life are they enjoying?
    And you, just appriciate the Covid then you have the chance to enjoy the air without 1000 PM2.5 in Delhi.
    The Economic Times